Lv42
480 积分 2022-11-25 加入
Discovery of a Novel Napabucasin Derivative B16 as a Potent STAT3 Inhibitor for the Treatment of Triple-Negative Breast Cancer
21小时前
已完结
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomas
2个月前
已完结
IL-18 drives the Bhlhe40-mediated pathogenic Th17 cell response and exacerbates autoimmune disease progression
2个月前
已完结
Targeting DHX9 helicase with the novel small-molecule inhibitor ATX968 induces replication stress and innate immunity in small cell lung cancer
2个月前
已关闭
Targeting CDK2 and other novel cell cycle targets for breast cancer therapy
3个月前
已完结
10PL8 and 2fPL8 inhibit gastric cancer cell proliferation by targeting degradation of CDK6 proteins to arrest the cell cycle
5个月前
已完结
Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024)
5个月前
已完结
皖公网安备34019202002308
